Hepatic drug-metabolizing enzyme induction and implications for preclinical and clinical risk assessment.
about
Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.Noscapine recirculates enterohepatically and induces self-clearance.Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach.The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.Application of the DataChip/MetaChip technology for the evaluation of ajoene toxicity in vitro.Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.Characterization of xenobiotic-induced hepatocellular enzyme induction in rats: anticipated thyroid effects and unique pituitary gland findings.Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
P2860
Q35873088-7472E2C2-AEB2-42C2-B90A-AF3BD36FE8C5Q35893886-F8DC8FBE-93D6-464B-88BD-A896F0FD0EC3Q37607932-A1ED9C54-344B-42A1-AD75-0A799C7C39B2Q38774776-D5FC3EE6-9E31-4FE4-92C5-38B88E83BEC6Q44740396-CD3F7DD8-3A2A-4CA8-8097-11BDAC75CB7AQ47565453-FE1E4424-9288-49AD-AF73-7BB5252D5CF4Q51466740-838EB969-069C-4459-8752-3EC00575131CQ53804885-9EECD1A3-BFCA-4760-A16E-EDF263F2A8A2
P2860
Hepatic drug-metabolizing enzyme induction and implications for preclinical and clinical risk assessment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@en
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@nl
type
label
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@en
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@nl
prefLabel
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@en
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@nl
P2093
P2860
P356
P1476
Hepatic drug-metabolizing enzy ...... and clinical risk assessment.
@en
P2093
Annette Romeike
John Fowler
Michael A Mohutsky
Sabine Francke-Carroll
Vince Meador
William M Lee
P2860
P304
P356
10.1177/0192623310375099
P407
P577
2010-07-08T00:00:00Z